Mar 12 |
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
|
Mar 5 |
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
|
Feb 26 |
Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024
|
Feb 20 |
Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024
|
Feb 13 |
Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
|
Jan 5 |
Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?
|
Dec 8 |
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
|
Dec 7 |
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)
|
Nov 24 |
13 Stocks Insiders are Buying Now
|
Nov 20 |
Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference
|